Volume 11, Issue 3 ( September 2019 2019)                   Iranian Journal of Blood and Cancer 2019, 11(3): 101-108 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Patel B K, Basu D, Kar R, Dubashi B. Immunophenotyping of Nodal Peripheral T-cell Lymphomas and its Association with Epstein-Barr Virus. Iranian Journal of Blood and Cancer 2019; 11 (3) :101-108
URL: http://ijbc.ir/article-1-884-en.html
1- Post Doctoral Fellow in Department of Cytogenetics
2- Senior Professor of Pathology
3- Additional Professor of Pathology
4- Additional Professor of Medical Oncology , drbiswajitdm@gmail.com
Abstract:   (3404 Views)
Background: Immunophenotyping in the rare group of nodal Peripheral T-cell Lymphomas (PTCL) exposes interesting features such as T-cell marker downregulation and paradoxically, the presence of reactive, clustered large-sized CD20 positive B-cells (B-cell proliferation). Epstein-Barr virus (EBV) has been suggested as a putative etiology in pathogenesis of B-cell lymphoma. We aimed to review the immunohistochemical profile of patients with nodal PTCL with emphasis on T-cell markers and immunophenotypic aberrations, CD20 positive large B-cells, Ki-67 scores (as a measure of proliferation index) and to assess the association of Epstein-Barr virus in various subtypes of nodal PTCL.
Methods: 80 cases of nodal PTCL diagnosed during January 2008-June 2013 were included in the study. Relevant clinical and hematological data were collected. Using Streptavidin-Biotin-Peroxidase system, staining for CD2, CD3, CD4, CD5, CD7, CD8, CD20,EBV-LMP1 and Ki-67 were performed on all blocks.CD10,CD23,Bcl-6, CD30 and ALK-1 were used in relevant cases.
Results: 95% of patients had downregulation of at least one T-cell marker (maximum: CD7 (87%), minimum: CD3 and CD5- 9% each). 29 patients (36%) showed markers of B-cell proliferation. Only five patients (6%) were positive for EBV-LMP1. There was a significant association between EBV-LMP1 positivity and B-cell proliferation (P=0.002). 17 patients (21%) had high Ki-67 index (≥80%).
Conclusion: Nodal PTCL showed frequent downregulation of T-cell markers. EBV was only infrequently positive in these Lymphomas. Clusters of large B-cells need to be noted in pathology reports and EBV needs to be tested for in such cases.
Full-Text [PDF 2544 kb]   (2011 Downloads)    
: Original Article | Subject: Pathology
Received: 2019/03/18 | Accepted: 2019/09/13 | Published: 2019/10/8

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb